{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/VYNE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T08:40:57.243Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11939,"canonical_name":"VYNE Therapeutics Inc.","cik":"0001566044","uei":null,"lei":null,"duns":null,"ticker":"VYNE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":64},"count":64,"timeline":[{"ts":"2026-10-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Yarrow Bioscience, Inc. — 2026-10-07","url_slug":"/sec/cik-0001566044/schedule-13g/0001104659-26-114282","accession_number":"0001104659-26-114282","importance":55},{"ts":"2026-09-17","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Yarrow Bioscience, Inc. — 2026-09-17","url_slug":"/sec/cik-0001566044/schedule-13g/0002005369-26-000053","accession_number":"0002005369-26-000053","importance":55},{"ts":"2026-09-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Yarrow Bioscience, Inc. — 2026-09-14","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-107485","accession_number":"0001104659-26-107485","importance":35},{"ts":"2026-09-11","kind":"sec.filing","form_type":"424B5","title":"424B5 — Yarrow Bioscience, Inc. — 2026-09-11","url_slug":"/sec/cik-0001566044/424b5/0001104659-26-107102","accession_number":"0001104659-26-107102","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"424B5","title":"424B5 — Yarrow Bioscience, Inc. — 2026-09-11","url_slug":"/sec/cik-0001566044/424b5/0001104659-26-107112","accession_number":"0001104659-26-107112","importance":30},{"ts":"2026-09-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Yarrow Bioscience, Inc. — 2026-09-10","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-106699","accession_number":"0001104659-26-106699","importance":35},{"ts":"2026-08-19","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Yarrow Bioscience, Inc. — 2026-08-19","url_slug":"/sec/cik-0001566044/effect/9999999995-26-002706","accession_number":"9999999995-26-002706","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Yarrow Bioscience, Inc. — 2026-08-14","url_slug":"/sec/cik-0001566044/schedule-13g/0000905148-26-003761","accession_number":"0000905148-26-003761","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Yarrow Bioscience, Inc. — 2026-08-14","url_slug":"/sec/cik-0001566044/schedule-13g/0001104659-26-097426","accession_number":"0001104659-26-097426","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Yarrow Bioscience, Inc. — 2026-08-14","url_slug":"/sec/cik-0001566044/pos-am/0001104659-26-096109","accession_number":"0001104659-26-096109","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Yarrow Bioscience, Inc. — 2026-08-13","url_slug":"/sec/cik-0001566044/10-q/0001566044-26-000010","accession_number":"0001566044-26-000010","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Yarrow Bioscience, Inc. — 2026-08-13","url_slug":"/sec/cik-0001566044/8-k-a/0001104659-26-095925","accession_number":"0001104659-26-095925","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Yarrow Bioscience, Inc. — 2026-08-13","url_slug":"/sec/cik-0001566044/schedule-13g-a/0002140685-26-000004","accession_number":"0002140685-26-000004","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Yarrow Bioscience, Inc. — 2026-08-07","url_slug":"/sec/cik-0001566044/schedule-13g-a/0000935836-26-000377","accession_number":"0000935836-26-000377","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Yarrow Bioscience, Inc. — 2026-08-04","url_slug":"/sec/cik-0001566044/schedule-13g/0000935836-26-000371","accession_number":"0000935836-26-000371","importance":55},{"ts":"2026-07-30","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Yarrow Bioscience, Inc. — 2026-07-30","url_slug":"/sec/cik-0001566044/schedule-13g/0001104659-26-088671","accession_number":"0001104659-26-088671","importance":55},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Yarrow Bioscience, Inc. — 2026-07-30","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-088662","accession_number":"0001104659-26-088662","importance":35},{"ts":"2026-07-29","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/schedule-13d-a/0001193125-26-323654","accession_number":"0001193125-26-323654","importance":70},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088352","accession_number":"0001104659-26-088352","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088353","accession_number":"0001104659-26-088353","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088355","accession_number":"0001104659-26-088355","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088359","accession_number":"0001104659-26-088359","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088363","accession_number":"0001104659-26-088363","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088366","accession_number":"0001104659-26-088366","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088367","accession_number":"0001104659-26-088367","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"3","title":"3 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/3/0001104659-26-088368","accession_number":"0001104659-26-088368","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"4","title":"4 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/4/0001104659-26-088370","accession_number":"0001104659-26-088370","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"4","title":"4 — Yarrow Bioscience, Inc. — 2026-07-29","url_slug":"/sec/cik-0001566044/4/0001104659-26-088371","accession_number":"0001104659-26-088371","importance":30},{"ts":"2026-07-29","kind":"sec.insider.j","reporter":"RTW Fund Group GP, LLC","title":"","shares":133290,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-29","kind":"sec.insider.j","reporter":"WONG RODERICK","title":"","shares":133290,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Yarrow Bioscience, Inc. — 2026-07-28","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-087601","accession_number":"0001104659-26-087601","importance":35},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-24","url_slug":"/sec/cik-0001566044/4/0001727756-26-000008","accession_number":"0001727756-26-000008","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-24","url_slug":"/sec/cik-0001566044/4/0001727794-26-000010","accession_number":"0001727794-26-000010","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-24","url_slug":"/sec/cik-0001566044/4/0001727809-26-000008","accession_number":"0001727809-26-000008","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-24","url_slug":"/sec/cik-0001566044/4/0001867033-26-000008","accession_number":"0001867033-26-000008","importance":30},{"ts":"2026-07-23","kind":"sec.insider.f","reporter":"Domzalski David","title":"PRESIDENT AND CEO","shares":79391,"price_per_share":0.8976,"usd_value":71261,"security_title":"Common Stock","importance":15.0712613616},{"ts":"2026-07-23","kind":"sec.insider.f","reporter":"Harsch Mutya","title":"CHIEF LEGAL OFFICER AND GC","shares":22516,"price_per_share":0.8976,"usd_value":20210,"security_title":"Common Stock","importance":15.0202103616},{"ts":"2026-07-23","kind":"sec.insider.f","reporter":"Zeronda Tyler","title":"CHIEF FINANCIAL OFFICER","shares":22516,"price_per_share":0.8976,"usd_value":20210,"security_title":"Common Stock","importance":15.0202103616},{"ts":"2026-07-23","kind":"sec.insider.f","reporter":"Stuart Iain","title":"CHIEF SCIENTIFIC OFFICER","shares":15405,"price_per_share":0.8976,"usd_value":13828,"security_title":"Common Stock","importance":15.013827528},{"ts":"2026-07-21","kind":"sec.filing","form_type":"8-K","title":"8-K — VYNE Therapeutics Inc. — 2026-07-21","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-085235","accession_number":"0001104659-26-085235","importance":35},{"ts":"2026-07-20","kind":"sec.filing","form_type":"8-K","title":"8-K — VYNE Therapeutics Inc. — 2026-07-20","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-084760","accession_number":"0001104659-26-084760","importance":35},{"ts":"2026-07-17","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — VYNE Therapeutics Inc. — 2026-07-17","url_slug":"/sec/cik-0001566044/schedule-13g-a/0002140685-26-000003","accession_number":"0002140685-26-000003","importance":30},{"ts":"2026-07-14","kind":"sec.filing","form_type":"8-K","title":"8-K — VYNE Therapeutics Inc. — 2026-07-14","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-083356","accession_number":"0001104659-26-083356","importance":35},{"ts":"2026-07-14","kind":"sec.filing","form_type":"425","title":"425 — VYNE Therapeutics Inc. — 2026-07-14","url_slug":"/sec/cik-0001566044/425/0001104659-26-083359","accession_number":"0001104659-26-083359","importance":30},{"ts":"2026-07-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — VYNE Therapeutics Inc. — 2026-07-14","url_slug":"/sec/cik-0001566044/schedule-13g-a/0002140685-26-000002","accession_number":"0002140685-26-000002","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"8-K","title":"8-K — VYNE Therapeutics Inc. — 2026-07-10","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-082433","accession_number":"0001104659-26-082433","importance":35},{"ts":"2026-07-10","kind":"sec.filing","form_type":"425","title":"425 — VYNE Therapeutics Inc. — 2026-07-10","url_slug":"/sec/cik-0001566044/425/0001104659-26-082434","accession_number":"0001104659-26-082434","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-02","url_slug":"/sec/cik-0001566044/4/0001727809-26-000006","accession_number":"0001727809-26-000006","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-02","url_slug":"/sec/cik-0001566044/4/0001867033-26-000006","accession_number":"0001867033-26-000006","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-02","url_slug":"/sec/cik-0001566044/4/0001727756-26-000006","accession_number":"0001727756-26-000006","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-07-02","url_slug":"/sec/cik-0001566044/4/0001727794-26-000008","accession_number":"0001727794-26-000008","importance":30},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Domzalski David","title":"PRESIDENT AND CEO","shares":12214,"price_per_share":0.6507,"usd_value":7948,"security_title":"Common Stock","importance":15.0079476498},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Harsch Mutya","title":"CHIEF LEGAL OFFICER AND GC","shares":3464,"price_per_share":0.6507,"usd_value":2254,"security_title":"Common Stock","importance":15.0022540248},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Zeronda Tyler","title":"CHIEF FINANCIAL OFFICER","shares":3464,"price_per_share":0.6507,"usd_value":2254,"security_title":"Common Stock","importance":15.0022540248},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Stuart Iain","title":"CHIEF SCIENTIFIC OFFICER","shares":2370,"price_per_share":0.6507,"usd_value":1542,"security_title":"Common Stock","importance":15.001542159},{"ts":"2026-06-16","kind":"sec.filing","form_type":"ARS","title":"ARS — VYNE Therapeutics Inc. — 2026-06-16","url_slug":"/sec/cik-0001566044/ars/0001104659-26-074386","accession_number":"0001104659-26-074386","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — VYNE Therapeutics Inc. — 2026-06-15","url_slug":"/sec/cik-0001566044/schedule-13g/0002140685-26-000001","accession_number":"0002140685-26-000001","importance":55},{"ts":"2026-06-15","kind":"sec.filing","form_type":"424B3","title":"424B3 — VYNE Therapeutics Inc. — 2026-06-15","url_slug":"/sec/cik-0001566044/424b3/0001104659-26-074092","accession_number":"0001104659-26-074092","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — VYNE Therapeutics Inc. — 2026-06-15","url_slug":"/sec/cik-0001566044/effect/9999999995-26-002010","accession_number":"9999999995-26-002010","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"S-4/A","title":"S-4/A — VYNE Therapeutics Inc. — 2026-06-03","url_slug":"/sec/cik-0001566044/s-4-a/0001104659-26-069925","accession_number":"0001104659-26-069925","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — VYNE Therapeutics Inc. — 2026-06-02","url_slug":"/sec/cik-0001566044/4/0001727794-26-000006","accession_number":"0001727794-26-000006","importance":30},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Domzalski David","title":"PRESIDENT AND CEO","shares":30791,"price_per_share":0.31,"usd_value":9545,"security_title":"Common Stock","importance":15.00954521},{"ts":"2026-05-21","kind":"sec.filing","form_type":"8-K","title":"8-K — VYNE Therapeutics Inc. — 2026-05-21","url_slug":"/sec/cik-0001566044/8-k/0001104659-26-065214","accession_number":"0001104659-26-065214","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — VYNE Therapeutics Inc. — 2026-05-15","url_slug":"/sec/cik-0001566044/10-q/0001566044-26-000005","accession_number":"0001566044-26-000005","importance":45}]}